US2006025868A1PendingUtilityA1

Method for treating diseased or damaged organs

50
Assignee: ORGANOGENESIS INCPriority: Feb 18, 1994Filed: Apr 12, 2005Published: Feb 2, 2006
Est. expiryFeb 18, 2014(expired)· nominal 20-yr term from priority
A61F 2002/30235A61F 2/06A61F 2240/001A61F 2002/30062Y10S623/917A61F 2/02A61L 27/58A61L 27/24A61F 2210/0004A61L 27/34A61F 2230/0069A61F 2002/30971
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention is directed to a method of treating a patient with diseased or damaged organs comprising administering to said patient a bioremodelable collagen-containing material which promotes the production of structural collagen, vascularization and epithelialization by the ingrowth of patient cells, wherein the material undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted graft is bioremodeled by the patient's living cells.

Claims

exact text as granted — not AI-modified
1 . A method of treating a patient with diseased or damaged organs comprising administering to said patient a bioremodelable collagen-containing material which promotes the production of structural collagen, vascularization and epithelialization by the ingrowth of patient cells  
   
   
       2 . The method of  claim 1 , wherein the material undergoes controlled biodegradation occurring with adequate living cell replacement such that the original material is bioremodeled by the patient's living cells.  
   
   
       3 . The method of  claim 1 , wherein the collagen in said material is acid-extracted fibrillar or non-fibrillar collagen, predominantly type I collagen.  
   
   
       4 . The method of  claim 1 , wherein the diseased or damaged organ is an artery or a vein.  
   
   
       5 . The method of  claim 1 , wherein the diseased or damaged organ is the esophagus, intestine, bowel, urethra, or fallopian tubes.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.